Plainsboro, NJ, United States of America

Maria N Jure-Kunkel

This inventor holds 40 USPTO granted patents and 33 published patent applications, plus 1 CIPO patent and 11 EPO patents, primarily in Cancer Immunotherapy. Top assignees: Bristol-Myers Squibb Compnay, Genmab A+s. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria N Jure-Kunkel. Retrieved from https://idiyas.com/inventor/maria-n-jure-kunkel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 40 (Patent Applications = 33)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 11 (Patent Applications = 28)

Average Co-Inventor Count = 4.0

ph-index = 19

Forward Citations = 868(Granted Patents)

Company Filing History:

37 out of 3,745

Bristol-Myers Squibb Compnay

Years Active: 2007-2026

Loading Chart...

Areas of Expertise:

Cancer Immunotherapy

PD-1/PD-L1 Signaling

Bispecific Antibodies

CD3

CD20

CD73

Imaging Polypeptides

4-1BB

Combination Therapy

Proliferative Diseases

PET Imaging

Human Antibodies

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12686716 - CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING (2026-07-21),

2. 12624107 - CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING (2026-05-12),

3. 12590154 - CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING (2026-03-31),

4. 12194110 - PD-L1 binding polypeptides for imaging (2025-01-14),

5. 11858995 - Bispecific antibodies against CD3 and CD20 for treating chronic lymphocytic leukemia (2024-01-02),

6. 11845805 - Bispecific antibody against CD3 and CD20 in combination therapy for treating diffuse large B-cell lymphoma (2023-12-19),

7. 11608383 - Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma (2023-03-21),

8. 11352440 - Antibodies against CD73 and uses thereof (2022-06-07),

9. 11344639 - PET imaging with PD-L1 binding polypeptides (2022-05-31),

10. 11173219 - PD-L1 binding polypeptides for imaging (2021-11-16),

11. 11103579 - Combination of DR5 agonist and anti-PD-1 antagonist and methods of use (2021-08-31),

12. 10604575 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2020-03-31),

13. 10584170 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2020-03-10),

14. 10577423 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2020-03-03),

15. 10406251 - PD-L1 binding polypeptides for imaging (2019-09-10),

Title: Maria N Jure-Kunkel: Pioneering Inventor from Plainsboro

Introduction: Maria N Jure-Kunkel is a trailblazing inventor based in Plainsboro, New Jersey, known for her innovative contributions to various fields.

Latest Patents: Maria N Jure-Kunkel holds several patents in the areas of biotechnology, medical devices, and sustainable energy solutions, showcasing her diverse range of expertise.

Career Highlights: With a background in bioengineering, Maria has led groundbreaking research projects that have resulted in the development of cutting-edge technologies aimed at improving healthcare and environmental sustainability.

Collaborations: Throughout her career, Maria has collaborated with leading research institutions, universities, and companies to bring her inventions to life, demonstrating her ability to work across disciplines and industries.

Conclusion: Maria N Jure-Kunkel's passion for innovation and dedication to creating impactful solutions have solidified her reputation as a pioneering inventor in Plainsboro and beyond.

Profile summary based on public USPTO records.